LIGAND PHARMACEUTICALS INCORPORATED Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIGAND PHARMACEUTICALS INCORPORATED payments for repurchase of warrants for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments for repurchase of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- LIGAND PHARMACEUTICALS INCORPORATED payments for repurchase of warrants for fiscal 2021 was $18.45M.
- LIGAND PHARMACEUTICALS INCORPORATED payments for repurchase of warrants for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2021-12-31 | $18.45M 10-K · filed 2024-02-29 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2019-12-31 | $380.00K 10-K · filed 2022-02-28 | |
| 2018-12-31 | $30.09M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |